Analyst Reco. Adagene Inc.

Equities

ADAG

US0053291078

Market Closed - Nasdaq Other stock markets 02:00:00 09/05/2024 am IST			5-day change	1st Jan Change
2.18 ^USD	-2.92%		-6.44%	+12.87%

29/03	Adagene Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
29/03	Adagene Inc. Announces Board Changes	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Morgan Stanley Adjusts Price Target on Adagene to $5 From $7, Maintains Overweight Rating	24/23/24	MT
HC Wainwright Starts Adagene at Buy With $5 Price Target	07/22/07	MT
Morgan Stanley Cuts Price Target on Adagene to $7 From $15, Maintains Overweight Rating	09/22/09	MT
Berenberg Emerging Biotech Conference	19/22/19	FA
Morgan Stanley Adjusts Adagene's Price Target to $15 From $27, Reiterates Overweight Rating	01/22/01	MT
Morgan Stanley Adjusts Adagene's Price Target to $27 from $33, Keeps Overweight Rating	06/22/06	MT
ADAGENE : Morgan Stanley Adjusts Price Target on Adagene to $33 From $34, Maintains Overweight Rating	16/21/16	MT
ADAGENE : China Renaissance Starts Adagene at Buy With $40.57 Price Target	25/21/25	MT
ADAGENE : Morgan Stanley Starts Adagene at Overweight With $34 Price Target	08/21/08	MT
ADAGENE : Jefferies & Co Initiates Coverage on Adagene With Buy Rating, $33 Price Target	08/21/08	MT
ADAGENE : Goldman Sachs Initiates Coverage on Adagene With Buy Rating, $29 Price Target	08/21/08	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW